Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Roblin

Showing results (61-70 of 252) with videos related to

Pageof 26
Sort By:
Journal of Clinical Medicine|November 27, 2025
Therapeutic Drug Monitoring in Special Circumstances in Inflammatory Bowel DiseaseSebastian Povlsen, Kamal Patel, Xavier Roblin, et al.
Gut Microbes|May 8, 2024
New methods to unveil host-microbe interaction mechanisms along the microbiota-gut-brain-axisHabibullah Moradian, Tristan Gabriel, Mathilde Barrau, et al.
Therapeutic Advances in Gastroenterology|March 14, 2017
Golimumab pharmacokinetics in ulcerative colitis: a literature reviewInes Harzallah, Josselin Rigaill, Nicolas Williet, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 28, 2012
Management of cytomegalovirus infection in inflammatory bowel diseasesSylvie Pillet, Bruno Pozzetto, Camille Jarlot, et al.
Expert Review of Anti-Infective Therapy|December 18, 2013
Quantification of cytomegalovirus viral loadSylvie Pillet, Xavier Roblin, Jérôme Cornillon, et al.
Journal of Crohn'S & Colitis|August 3, 2016
Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn's and Ulcerative Colitis AssociationsLaurent Peyrin-Biroulet, Sanna Lönnfors, Xavier Roblin, et al.
Digestive Diseases and Sciences|April 17, 2007
Biermer's anemia: a new cause of cholestasis and hepatic steatosis?Xavier Roblin, Maud Genevois, V Ducros, et al.
Gastroenterologie Clinique Et Biologique|June 19, 2002
[Unexplained increase in aminotransferases and obstructive sleep apnea syndrome]Xavier Roblin, Thierry Boudemaghe, Françoise Paris, et al.
Journal of Gastroenterology|September 26, 2016
Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic reviewLaura Martelli, Pablo Olivera, Xavier Roblin, et al.
BMC Immunology|December 26, 2021
Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501)Fabien Francois, Loubna Naimi, Xavier Roblin, et al.
Pageof 26

Showing results (61-70 of 252) with videos related to

Sort By:
Pageof 26
Journal of Clinical Medicine|November 27, 2025
Therapeutic Drug Monitoring in Special Circumstances in Inflammatory Bowel DiseaseSebastian Povlsen, Kamal Patel, Xavier Roblin, et al.
Gut Microbes|May 8, 2024
New methods to unveil host-microbe interaction mechanisms along the microbiota-gut-brain-axisHabibullah Moradian, Tristan Gabriel, Mathilde Barrau, et al.
Therapeutic Advances in Gastroenterology|March 14, 2017
Golimumab pharmacokinetics in ulcerative colitis: a literature reviewInes Harzallah, Josselin Rigaill, Nicolas Williet, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 28, 2012
Management of cytomegalovirus infection in inflammatory bowel diseasesSylvie Pillet, Bruno Pozzetto, Camille Jarlot, et al.
Expert Review of Anti-Infective Therapy|December 18, 2013
Quantification of cytomegalovirus viral loadSylvie Pillet, Xavier Roblin, Jérôme Cornillon, et al.
Journal of Crohn'S & Colitis|August 3, 2016
Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn's and Ulcerative Colitis AssociationsLaurent Peyrin-Biroulet, Sanna Lönnfors, Xavier Roblin, et al.
Digestive Diseases and Sciences|April 17, 2007
Biermer's anemia: a new cause of cholestasis and hepatic steatosis?Xavier Roblin, Maud Genevois, V Ducros, et al.
Gastroenterologie Clinique Et Biologique|June 19, 2002
[Unexplained increase in aminotransferases and obstructive sleep apnea syndrome]Xavier Roblin, Thierry Boudemaghe, Françoise Paris, et al.
Journal of Gastroenterology|September 26, 2016
Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic reviewLaura Martelli, Pablo Olivera, Xavier Roblin, et al.
BMC Immunology|December 26, 2021
Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501)Fabien Francois, Loubna Naimi, Xavier Roblin, et al.
Pageof 26